Pathophysiology Master Notes - JBU NUR3114 Exam Guide
How to Use This Guide
- Core Study Framework: Reorganized around JBU chapter objectives and Gould lecture materials, focusing on bolded cause-to-effect chains.
- Four Key Clinical Questions: For every disorder or concept, be prepared to answer:
- What starts the problem?
- What changes physiologically?
- Why do the manifestations occur?
- What complication or patient finding is most urgent?
- Core Exam Habit: Never memorize a manifestation in isolation. Always connect it directly to its underlying mechanism (e.g., histamine release increases capillary permeability → protein and fluid leak into interstitial space → edema develops → circulating vascular volume drops).
- Chapter Tooling: Use objective checklists to verify instructor expectations, rapid review sections for fast recall, and NCLEX/pathophysiology reasoning boxes for clinical application questions.
Chapter 1 - Basic Concepts of Disease and Cellular Change
Pathophysiology and Homeostasis
- Pathophysiology Defined: The study of functional or physiological changes in the body that result from disease processes. It connects normal anatomy and physiology with clinical manifestations.
- Pathology vs. Pathophysiology: Pathology focuses on structural changes in tissues; pathophysiology explains how structural and functional changes alter bodily performance.
- Homeostasis: The maintenance of a relatively stable internal environment regardless of external changes.
- Maintained via continuous dynamic feedback systems adjusting key variables (temperature, blood pressure, blood glucose, fluid volume, electrolytes, oxygen, carbon dioxide, and pH).
- Disease develops when a stressor overwhelms compensatory mechanisms or when control systems themselves fail.
- Health: State of complete physical, mental, and social well-being, not merely the absence of disease.
- Disease: A deviation from the normal state of homeostasis in which the body cannot maintain stability.
- "Normal" values represent a range based on population statistics rather than an absolute single number, varying with age, sex, genetics, environment, activity level, measurement method, and individual baseline.
- Overarching Concept: Manifestations are direct evidence of altered physiological function. Always determine which homeostatic variable changed, how the body is compensating, and whether compensation is succeeding or failing.
Disease Terminology
- Diagnosis: Identification of a specific disease through evaluation of patient history, manifestations, physical examination, and laboratory/diagnostic tests.
- Etiology: The cause or contributing factors of a disease.
- Idiopathic: Refers to a disease or condition with an unknown cause.
- Iatrogenic: A condition or injury inadvertently caused by a medical treatment, procedure, medication, or healthcare error.
- Predisposing/Risk Factor: A factor that increases a person's vulnerability or probability of developing a disease, though it is not the direct trigger (e.g., age, heredity, lifestyle, environment, chronic disease).
- Pathogenesis: The precise sequence of cellular and tissue events during the development of a disease from initial onset to full manifestation.
- Manifestation: Clinical evidence or display of disease; encompasses both objective signs and subjective symptoms.
- Sign: Objective, measurable, or observable clinical evidence (e.g., fever, rash, blood pressure value, abnormal laboratory result).
- Symptom: Subjective experience reported by the patient (e.g., pain, nausea, dizziness, fatigue).
- Lesion: A localized structural change or anatomical lesion in tissue (e.g., blister, ulcer, tumor).
- Syndrome: A specific collection of signs and symptoms that consistently occur together in a recognizable pattern.
- Prognosis: The predicted outcome or course of a disease, including likelihood of recovery, disability, recurrence, or mortality.
- Morbidity: The rate or burden of disease within a specified population.
- Mortality: The number or percentage of deaths caused by a specific disease.
- Incidence: The number of newly diagnosed cases of a disease arising within a specified time frame.
- Prevalence: The total number of existing cases (both new and old) within a specific population at a given point or period in time.
- Incidence vs. Prevalence: Incidence reflects the risk of contracting a disease; prevalence reflects how widespread the disease is. Chronic conditions have modest incidence but high prevalence due to patient survival.
Etiologic Categories
- Common Causes of Disease:
- Congenital defects
- Inherited or genetic disorders
- Microorganisms (bacteria, viruses, fungi, parasites)
- Immune dysfunction (hypersensitivity, autoimmunity, immunodeficiency)
- Degenerative cellular changes
- Malignancy / Neoplasia
- Metabolic or nutritional imbalances
- Physical trauma, thermal burns, or environmental exposures
- Iatrogenic/treatment-related injuries
- Multifactorial Etiology: Diseases frequently result from interactions between predisposing risk factors and acute triggers.
- Medical History Components: Vital for determining underlying cause and risk; includes present/past illnesses, drug allergies, hospitalizations, surgical procedures, current medications (prescription, OTC, herbal), dietary habits, environmental hazards, and functional limitations.
Course of Disease
- Acute: Characterized by sudden, rapid onset and short duration; manifestations are often severe and intense.
- Chronic: Mild or gradual onset, persisting over a prolonged period; often characterized by acute exacerbations and remissions.
- Subclinical: Pathological changes occur without obvious clinical manifestations; host may still transmit infection or sustain tissue damage.
- Latent: Silent phase where disease agent or pathogen is present but inactive/dormant; no clinical evidence is present, but reactivation can occur later.
- Incubation Period: In infectious disease, the time interval between entry of the infectious agent into the body and the first appearance of clinical manifestations.
- Prodromal Period: Early phase characterized by nonspecific, vague manifestations (e.g., fatigue, malaise, headache, anorexia) signaling the onset of illness.
- Acute / Clinical Period: Stage when disease manifestations reach peak intensity and characteristic diagnostic features are fully evident.
- Remission: Period during which disease manifestations diminish or disappear entirely; does not automatically indicate a complete cure.
- Exacerbation: Sudden increase in the severity of disease signs and symptoms.
- Precipitating Factor: An acute trigger or event that provokes a disease episode or exacerbation.
- Complication: A secondary, new, or additional physiological problem arising from the original disease or its treatment.
- Sequela: Potential unwanted residual outcomes or permanent damage remaining after the acute phase of a disease has resolved.
- Disease Outcomes: Complete recovery, partial recovery with residual deficit, conversion to chronic status, pattern of remissions/recurrences, severe disability, or death.
Levels of Prevention
- Primary Prevention: Measures taken to prevent disease or injury before it occurs.
- Examples: Immunizations, smoking cessation, healthy diet, regular exercise, sun protection, safety equipment.
- Secondary Prevention: Early detection and intervention to stop or limit disease progression before major damage occurs.
- Examples: Routine blood pressure screenings, mammograms, Pap smears, blood glucose screening, early diagnostic testing.
- Exam Trap: Screening tests are classified as secondary, not primary, prevention.
- Tertiary Prevention: Managing established, chronic disease to prevent further disability, limit complications, and maximize functional capacity.
- Examples: Post-stroke physical rehabilitation, cardiac rehabilitation, blood glucose control in established diabetes, occupational therapy.
Cellular Adaptations
- Adaptation Concept: Cells respond to physiological or environmental stress by altering their size, number, or structure to survive. Prolonged stress can reduce functional capacity or lead to premalignant changes.
- Atrophy: Decrease in individual cell size, resulting in reduced tissue or organ mass.
- Causes: Reduced workload, disuse, denervation, ischemia, malnutrition, loss of hormonal stimulation, normal aging.
- Example: Skeletal muscle wasting in an immobilized casted limb.
- Hypertrophy: Increase in individual cell size, resulting in enlarged tissue mass without an increase in cell number.
- Causes: Increased functional demand or excessive hormonal stimulation.
- Example: Skeletal muscle growth from weightlifting; left ventricular enlargement from chronic hypertension.
- Hyperplasia: Increase in the total number of cells due to increased mitotic division.
- Occurs in: Tissues capable of mitotic division (epithelial, glandular, connective tissue).
- Types: Physiologic (uterine enlargement during pregnancy) or pathologic (endometrial hyperplasia from excess estrogen).
- Cell Size vs. Cell Number: Hypertrophy = larger cells. Hyperplasia = more cells.
- Metaplasia: Reversible substitution of one mature cell type by another mature cell type that is better able to withstand a chronic environmental stressor.
- Example: Substitution of pseudostratified ciliated columnar epithelium with stratified squamous epithelium in chronic smokers' airways.
- Consequence: Replacement cells tolerate irritation better but lack specialized functional traits (e.g., ciliated clearance).
- Dysplasia: Disordered cellular growth resulting in cells that vary abnormally in size, shape, nuclear appearance, and tissue organization.
- Characteristics: Often triggered by chronic irritation or infection; potentially reversible if the trigger is removed, but strongly regarded as a precancerous change.
- Anaplasia: Complete loss of cellular differentiation and organization; cells lose specialized function and exhibit marked nuclear abnormalities.
- Significance: Characteristic hallmark of aggressive malignant neoplasms ("cells have lost their identity").
- Neoplasia: Uncontrolled, autonomous cell growth forming an abnormal mass (neoplasm or tumor).
- Types: Benign (localized, non-invasive) or malignant (invasive, capable of metastasis). Growth persists independent of normal physiological controls.
Causes and Mechanisms of Cell Injury
- Major Etiologies of Cellular Injury:
- Oxygen deprivation (hypoxia or ischemia)
- Physical forces (extreme thermal temperatures, ionizing radiation, mechanical trauma, pressure shifts)
- Chemical agents (exogenous poisons, heavy metals, alcohol, drugs; endogenous toxic metabolic wastes)
- Infectious microorganisms (bacteria, viruses, fungi, parasites)
- Nutritional imbalances (vitamin deficiencies or caloric overload/obesity)
- Genetic and metabolic defects (mutated enzymes, abnormal protein accumulation)
- Fluid, electrolyte, and acid-base imbalances
- Hypoxia vs. Ischemia Mechanism:
- Hypoxia: Inadequate oxygen delivery to tissues. Disrupts oxidative phosphorylation, leading to a drop in intracellular ATP production.
- Ischemia: Compromised arterial blood supply to tissue. Causes hypoxia plus deprives tissue of vital metabolic substrates (glucose) and prevents the removal of metabolic waste products.
- Comparison: Ischemia injures cells significantly faster than isolated hypoxia.
- Pathophysiological Injury Cascade:
- Reduced oxygen/ATP → Failure of ATP-dependent Na+/K+ ATPase pumps → Na+ and water rush into the cell while K+ diffuses out → Acute cellular swelling (hydropic change) → Organelle membrane disruption and intracellular calcium accumulation → Activation of destructive intracellular enzymes (proteases, endonucleases, phospholipases) → Irreversible membrane damage and cell lysis.
Cell Death
- Apoptosis: Programmed, genetically regulated cell death.
- Mechanism: Controlled enzymatic breakdown of DNA and cytoplasmic structures; cellular contents are neatly packaged into apoptotic bodies and phagocytosed.
- Inflammatory Effect: Minimal to no surrounding inflammatory reaction because intracellular contents are not released into extracellular space.
- Context: Physiologic (embryonic tissue remodeling) or pathologic (removal of mutated/damaged cells).
- Pyroptosis: Programmed inflammatory cell death driven by inflammasomes.
- Mechanism: Cell swelling followed by pore formation, rupture, and release of pro-inflammatory cytokines (like IL−1β).
- Inflammatory Effect: Triggers severe surrounding inflammatory response.
- Necrosis: Uncontrolled cellular death following severe, lethal injury.
- Mechanism: Cell swelling, loss of membrane integrity, organelle breakdown, and passive cell lysis.
- Inflammatory Effect: Intracellular lysosomal enzymes and inflammatory mediators leak into surrounding interstitial space, damaging neighboring tissue and provoking acute inflammation.
Patterns of Tissue Necrosis
- Liquefactive Necrosis: Dead tissue is rapidly digested by hydrolytic lysosomal enzymes into a liquid, viscous mass.
- Classic Settings: Ischemic brain injuries/strokes and bacterial abscesses.
- Coagulative Necrosis: Denaturation of structural cellular proteins occurs, preserving the basic architecture of the dead tissue for several days.
- Classic Settings: Myocardial infarction and ischemic tissue necrosis in solid visceral organs (kidneys, spleen, heart).
- Fat Necrosis: Action of pancreatic lipases or direct trauma breaks down triglycerides into free fatty acids, which combine with extracellular calcium to form white, chalky soaps (saponification).
- Classic Settings: Acute pancreatitis and breast tissue trauma.
- Caseous Necrosis: A unique form of coagulative necrosis where dead tissue transforms into a soft, crumbly, friable, yellow-white "cheesy" appearance.
- Classic Setting: Tuberculosis granulomas (Ghon complexes).
- Infarction: An area of localized ischemic necrosis within a tissue or organ caused by sudden interruption of arterial blood supply or venous drainage.
- Gangrene: An extensive area of necrotic tissue subsequently modified by environmental exposure or microbial invasion.
- Dry Gangrene: Result of gradual ischemic necrosis (coagulative); tissue becomes dry, shriveled, wrinkled, dark brown/black, with a clear line of demarcation. Infection is absent.
- Wet Gangrene: Extensive necrosis resulting from venous stasis or bacterial superinfection; tissue becomes cold, swollen, soft, black, liquefactive, and foul-smelling. Spreads rapidly without demarcation.
- Gas Gangrene: Infection of necrotic tissue by anaerobic spore-forming bacteria (e.g., Clostridium perfringens); bacteria release destructive exotoxins and produce gas bubbles within tissues. Rapidly fatal medical emergency.
NCLEX / Pathophysiology Connections & Rapid Review
- Measurable temperature of 102∘F is an objective sign; patient reporting feeling chilly is a subjective symptom.
- Administering influenza vaccines is primary prevention; conducting routine Pap smears is secondary prevention; cardiac rehab after MI is tertiary prevention.
- Concentric left ventricular hypertrophy from chronic hypertension is hypertrophy because adult cardiac muscle cells cannot undergo mitosis.
- Conversion of respiratory columnar epithelium to squamous cells in response to smoke irritation is metaplasia.
- Undifferentiated tumor cells displaying abnormal nuclear configurations exhibit anaplasia.
- Ischemia causes rapid cell death because it deprives tissue of oxygen AND glucose while trapping metabolic waste.
- Necrosis provokes significant tissue inflammation; apoptosis is controlled and non-inflammatory.
- Rapid Review Formulae:
- Pathophysiology = Altered organ function due to disease.
- Etiology = Original cause.
- Pathogenesis = Step-by-step disease development.
- Atrophy = Decreased cell size.
- Hypertrophy = Increased cell size.
- Hyperplasia = Increased cell number.
- Metaplasia = Reversible cell type substitution.
- Dysplasia = Disorganized growth.
- Anaplasia = Undifferentiated malignant cells.
Chapter 2 - Fluid, Electrolyte, and Acid-Base Imbalances
Fluid Compartments and Lifespan
- Intracellular Fluid (ICF): Fluid situated within individual cell membranes; accounts for approximately two-thirds of total body water (67%).
- Extracellular Fluid (ECF): Fluid situated outside of cells; accounts for approximately one-third of total body water (33%).
- Intravascular Fluid (Plasma): Fluid within the vascular blood vessels.
- Interstitial Fluid (ISF): Fluid located in the spaces between tissue cells.
- Transcellular Fluid: Specialized fluids in specific body cavities (e.g., CSF, pericardial, pleural, synovial, peritoneal fluids).
- Total Body Water (TBW) by Population:
- Infants: 70% or higher of total body weight.
- Adult Males: Approximately 60% of total body weight.
- Adult Females: Approximately 50% of total body weight (higher percentage of adipose tissue).
- Older Adult Females: Approximately 45% of total body weight.
- Lifespan Considerations:
- Infants: Exceptionally vulnerable to rapid fluid volume shifts due to high metabolic rate, immature renal concentrating mechanisms, large surface area-to-volume ratio, and high insensible water loss. Fluid loss results in acute dehydration rapidly.
- Older Adults: High risk for dehydration due to reduced total body water percentage, diminished hypothalamic thirst perception, declining renal GFR/concentrating capability, and potential reliance on caregivers for hydration.
Regulation of Water and Sodium
- Thirst Mechanism: Hypothalamic osmoreceptors detect increased ECF osmolality or severe intravascular volume depletion → triggers conscious thirst drive to promote oral intake.
- Antidiuretic Hormone (ADH / Vasopressin):
- Trigger: Released from the posterior pituitary gland in response to elevated ECF osmolality or decreased circulating blood volume.
- Action: Inserts aquaporins into renal collecting ducts → increases renal reabsorption of free water back into vascular space → produces a lower volume of highly concentrated urine.
- Renin-Angiotensin-Aldosterone System (RAAS):
- Trigger: Decreased renal arterial perfusion pressure, low circulating volume, or low serum Na+ detected at juxtaglomerular apparatus.
- Cascade: Renin converts Angiotensinogen → Angiotensin I → Angiotensin converting enzyme (ACE) converts to Angiotensin II → stimulates adrenal cortex to release Aldosterone.
- Action: Aldosterone promotes active renal tubule reabsorption of Na+ and excretion of K+ and H+. Water passively follows sodium, expanding ECF volume.
- Atrial and Brain Natriuretic Peptides (ANP and BNP):
- Trigger: Released by stretched atrial and ventricular cardiac myocytes during fluid volume overload/elevated arterial pressure.
- Action: Inhibits aldosterone secretion, renin release, and ADH → promotes renal Na+ and water excretion (natriuresis and diuresis) to drop blood volume and pressure.
- Regulatory Memory Key:
- ADH = Free water retention.
- Aldosterone = Sodium retention (water follows) and Potassium excretion.
- ANP/BNP = Sodium and water excretion.
Movement Between Compartments
- Diffusion: Passive movement of solute particles down a concentration gradient from an area of higher solute concentration to an area of lower solute concentration (e.g., gas exchange of O2 and CO2 across alveolar capillary membrane).
- Osmosis: Passive movement of water molecules across a semipermeable membrane from a solution of lower solute concentration to a solution of higher effective solute concentration.
- Filtration: Movement of water and micro-solutes across a membrane driven by physical fluid pressure gradients.
- Active Transport: Energy-requiring (ATP) transport of solutes against a concentration gradient (e.g., Na+/K+ ATPase pump pumping 3Na+ out and 2K+ into cells).
- Capillary Hydrostatic Pressure (CHP): The outward physical "pushing" force exerted by fluid against capillary vascular walls. Drives water, electrolytes, and nutrients out of the arterial capillary into the interstitial space.
- Capillary Oncotic / Colloid Osmotic Pressure (COP): The inward osmotic "pulling" force exerted by large plasma proteins (primarily albumin) retained in the intravascular space. Pulls water and interstitial waste back into the venous capillary.
- Starling Forces at the Capillary Bed:
- Arterial End: CHP>COP → Net filtration outwards into interstitial space.
- Venous End: COP>CHP → Net fluid reabsorption inwards into capillary.
- Lymphatic System: Collects excess interstitial fluid and filtered plasma proteins, returning them to venous circulation.
Tonicity and Volume Changes
- Tonicity Defined: The effective osmotic pressure gradient produced by solute concentrations across a semipermeable cell membrane.
- Isotonic Fluid Shift: ECF and ICF have identical effective osmolalities. No net osmotic water movement across cell membranes. Cell volume remains unchanged.
- Hypotonic ECF: ECF has a lower effective solute concentration (lower osmolality) than ICF. Water rapidly moves down osmotic gradient from ECF into cells → Cells swell (risk for cellular lysis).
- Hypertonic ECF: ECF has a higher effective solute concentration (higher osmolality) than ICF. Water is drawn down osmotic gradient out of cells into ECF → Cells shrink / crenate.
- Clinical Signs of Volume Excess vs. Deficit:
- Fluid Volume Excess: Acute weight gain, bounding peripheral pulses, elevated blood pressure, jugular venous distention (JVD), peripheral pitting edema, pulmonary crackles, dyspnea, ascites.
- Fluid Volume Deficit: Acute weight loss, tachycardia, weak thready pulse, orthostatic hypotension, dry mucous membranes, decreased skin turgor (tenting), oliguria, concentrated dark urine, delayed capillary refill.
Edema
- Definition: Excessive accumulation of fluid in the interstitial compartment resulting in tissue swelling. Can be localized or generalized (anasarca).
Four Primary Mechanisms of Edema
- Increased Capillary Hydrostatic Pressure:
- Mechanism: Elevated intravascular pressure pushes excess water out of capillaries into interstitial spaces.
- Etiologies: Congestive heart failure, renal failure with volume retention, deep vein thrombosis (DVT), venous insufficiency, prolonged standing.
- Decreased Plasma Oncotic Pressure:
- Mechanism: Reduced circulating plasma protein concentration (hypoalbuminemia) lowers capillary osmotic pull, preventing water reabsorption from tissue spaces.
- Etiologies: Severe liver cirrhosis (impaired albumin synthesis), nephrotic syndrome (urinary albumin loss), severe protein-calorie malnutrition (kwashiorkor), extensive burn recovery.
- Increased Capillary Permeability:
- Mechanism: Endothelial cells contract or sustain damage, creating widened inter-endothelial gaps that allow plasma proteins to leak directly into the interstitial space. Interstitial oncotic pressure rises, pulling water into tissues.
- Etiologies: Acute inflammation, severe allergic reactions (anaphylaxis), tissue trauma, extensive burns, sepsis.
- Lymphatic Obstruction (Lymphedema):
- Mechanism: Interrupted lymphatic drainage prevents normal clearance of interstitial proteins and fluid, trapping protein-rich fluid in tissues.
- Etiologies: Surgical lymph node dissection (e.g., post-mastectomy), radiation therapy, tumor compression, filariasis.
- Effects of Edema: Pitting vs. non-pitting swelling, localized pain and tissue tightness, impaired arterial circulation resulting in tissue hypoxia and necrosis, delayed wound healing, decreased functional joint mobility, reduced vital capacity in pulmonary edema, elevated intracranial pressure in cerebral edema.
Dehydration and Hypovolemia
- Dehydration: Insufficient total body water caused by inadequate intake, excessive fluid losses, or a combination of both.
- Etiologies: Vomiting, severe diarrhea, excessive sweating (diaphoresis), diabetic ketoacidosis (osmotic diuresis from hyperglycemia), fever, hyperventilation, burn injuries, impaired thirst mechanism.
- Hemodynamic Pathophysiology:
- Fluid loss drops vascular volume → Decreased venous return to heart → Decreased end-diastolic volume → Reduced stroke volume and cardiac output → Systemic arterial hypotension.
- Compensatory Response: Sympathetic nervous system activation increases heart rate (tachycardia) and peripheral vascular resistance (vasoconstriction); RAAS and ADH activate to conserve water and Na+.
- Laboratory Marker: Relative hemoconcentration → elevated Hematocrit (Hct) and serum sodium/BUN levels due to decreased plasma volume.
Third Spacing
- Definition: Pathological shift of body fluid out of the intravascular compartment into non-functional body spaces (interstitial tissue spaces, peritoneal cavity, pleural cavity, pericardial space) where it is physiologically unavailable as circulating volume.
- Pathophysiological Paradox: Patient exhibits severe peripheral or generalized edema while simultaneously suffering from life-threatening intravascular volume depletion and hypovolemic shock.
- Clinical Triggers: Major burn injury, severe acute pancreatitis, peritonitis, extensive sepsis, crushing trauma.
- Clinical Manifestations: Severe edema coexisting with low blood pressure, compensatory tachycardia, oliguria, cool pale extremities, and thread pulses.
Sodium Imbalance
- Normal Range: Serum Na+:135–145mEq/L. Primary extracellular cation; crucial for maintaining ECF volume, osmotic pressure, and nerve impulse conduction.
Hyponatremia (Na+<135mEq/L)
- Etiologies: Excessive sweating, vomiting, diarrhea, loop/thiazide diuretic overuse, adrenal insufficiency (low aldosterone), Syndrome of Inappropriate Antidiuretic Hormone (SIADH), excessive intake of hypotonic free water, heart failure/cirrhosis (dilutional).
- Pathophysiology: Decreased ECF Na+ lowers ECF osmolality relative to ICF → Water rapidly shifts down osmotic gradient into intracellular compartment → Intracellular / neuronal edema.
- Clinical Manifestations: Dominated by neurological impairment: headache, confusion, lethargy, muscle weakness/cramps, seizures, coma, respiratory arrest.
- Correction Danger: Rapid overcorrection of severe hyponatremia with hypertonic saline can cause central pontine myelinolysis (osmotic demyelination syndrome).
Hypernatremia (Na+>145mEq/L)
- Etiologies: Inadequate water intake, unreplaced insensible fluid losses, Diabetes Insipidus (lack of ADH or renal unresponsiveness), profuse watery diarrhea, hypertonic IV fluid administration, primary hyperaldosteronism.
- Pathophysiology: Elevated ECF Na+ raises ECF osmolality relative to ICF → Water is pulled out of cells down osmotic gradient into ECF → Intracellular / neuronal dehydration / shrinkage.
- Clinical Manifestations: Intense thirst, dry sticky mucous membranes, agitation, restlessness, hyperreflexia, muscle twitching, seizures, coma.
Potassium Imbalance
- Normal Range: Serum K+:3.5–5.0mEq/L. Major intracellular cation; primary determinant of resting membrane potential in excitable tissues (cardiac, nerve, skeletal muscle cells).
Hypokalemia (K+<3.5mEq/L)
- Etiologies: Severe vomiting, prolonged diarrhea, loop or thiazide diuretics, hyperaldosteronism, excessive glucocorticoids, alkalosis (drives K+ into cells in exchange for H+), insulin administration (drives glucose and K+ into cells).
- Clinical Manifestations: Cardiac dysrhythmias, flattened T waves, prominent U waves, skeletal muscle weakness, cramps, paresthesias, hyporeflexia, constipation, paralytic ileus, shallow respirations due to respiratory muscle weakness.
- DKA Clinical Pitfall: Patients presenting with Diabetic Ketoacidosis (DKA) may initially have normal or elevated serum K+ due to acidotic cellular shifts. Administering insulin rapidly drives K+ back into cells, precipitating life-threatening hypokalemia if not supplemented.
Hyperkalemia (K+>5.0mEq/L)
- Etiologies: Acute or chronic renal failure (impaired renal excretion), hypoaldosteronism (Addison's disease), potassium-sparing diuretics (spironolactone), extensive cell trauma/crush injury/hemolysis (releases intracellular K+), severe uncompensated acidosis (drives K+ out of cells in exchange for H+).
- Clinical Manifestations: Muscle weakness, paresthesias, intestinal colic, hyperactive bowel sounds, ascending flaccid paralysis. Cardiac Risk: Peaked T waves, widened QRS, PR prolongation, progressing to ventricular fibrillation or cardiac arrest.
Potassium and pH Relationship
- Acidosis Effect: Systemic accumulation of H+ ions causes H+ to move into cells; to maintain electrical neutrality, K+ shifts out of cells into ECF → Hyperkalemia.
- Alkalosis Effect: Low extracellular H+ causes H+ to leave cells; K+ shifts out of ECF into cells → Hypokalemia.
Calcium Imbalance
- Normal Range: Total serum Ca2+:8.5–10.5mg/dL. Essential for structural bone matrix, blood coagulation, enzymatic cascades, neuromuscular membrane stability, and myocardial contraction.
- Hormonal Regulation:
- Parathyroid Hormone (PTH): Increases serum Ca2+ by stimulating bone resorption, enhancing renal tubular Ca2+ reabsorption, and activating Vitamin D.
- Vitamin D: Enhances dietary Ca2+ absorption in gastrointestinal tract.
- Calcitonin: Released by thyroid parafollicular cells; depresses serum Ca2+ by inhibiting bone resorption.
Hypocalcemia (Ca2+<8.5mg/dL)
- Etiologies: Hypoparathyroidism (surgical excision), severe Vitamin D deficiency, malabsorption syndromes, chronic kidney disease (impaired Vitamin D activation and hyperphosphatemia), acute pancreatitis, alkalosis (increases Ca2+ binding to albumin, reducing free ionized Ca2+).
- Pathophysiology: Low extracellular Ca2+ increases sodium permeability across nerve cell membranes, lowering threshold potential → Hyper-excitability of nervous system.
- Clinical Manifestations: Parethesias (perioral, fingers, toes), muscle twitching, abdominal cramps, carpopedal spasm, laryngeal spasm (airway obstruction), seizures.
- Chvostek's Sign: Unilateral facial muscle twitching elicited by tapping facial nerve anterior to earlobe.
- Trousseau's Sign: Carpopedal spasm induced by inflating blood pressure cuff above systolic pressure for 3 minutes.
Hypercalcemia (Ca2+>10.5mg/dL)
- Etiologies: Hyperparathyroidism, bone metastases/malignancy (osteoclast activation), prolonged immobility, Vitamin D toxicity, milk-alkali syndrome.
- Pathophysiology: High extracellular Ca2+ stabilizes neuronal membranes, reducing sodium permeability and suppressing electrical conduction → Depressed neuromuscular excitability.
- Clinical Manifestations: Skeletal muscle weakness, lethargy, hyporeflexia, confusion, memory impairment, anorexia, nausea, constipation ("groans"), polyuria, dehydration, nephrolithiasis ("stones"), cardiac dysrhythmias.
Magnesium, Phosphate, and Chloride
- Magnesium (Mg2+): Normal range 1.5–2.5mEq/L. Enzymatic cofactor for ATP reactions and neuromuscular regulator.
- Hypomagnesemia: Caused by chronic alcoholism, malnutrition, loop diuretics. Manifests with muscle tremors, hyperreflexia, tetany, positive Chvostek/Trousseau signs, cardiac dysrhythmias (Torsades de Pointes).
- Hypermagnesemia: Caused by renal failure or excessive intake. Manifests with depressed neuromuscular activity, hyporeflexia, hypotension, bradycardia, respiratory depression.
- Phosphate (PO43−): Normal range 2.5–4.5mg/dL. Required for ATP synthesis, cell membrane phospholipids, and acid-base buffering. Reciprocal inverse relationship with calcium (↑Ca2+→↓PO43−).
- Hypophosphatemia: Caused by refeeding syndrome, alkalosis. Leads to ATP depletion, respiratory muscle fatigue, impaired oxygen delivery.
- Hyperphosphatemia: Caused by chronic renal disease. Binds serum calcium, inducing hypocalcemia.
- Chloride (Cl−): Normal range 98–106mEq/L. Major extracellular anion. Follows sodium passively. Loss of gastric HCl via prolonged vomiting or nasogastric suction leads to hypochloremic metabolic alkalosis.
Acid-Base Foundations
- Normal Arterial Blood Gas (ABG) Values:
- pH:7.35–7.45
- PaCO2:35–45mmHg (Respiratory Component; volatile acid)
- HCO3−:22–26mEq/L (Metabolic Component; renal base)
- Carbonic Acid-Bicarbonate Equilibrium Equation:
CO2+H2O⇌H2CO3⇌H++HCO3−
- Pathophysiological Rationale: Accumulation of CO2 drives reaction right, increasing H+ and lowering pH (acidosis). Clearing CO2 shifts reaction left, consuming H+ and raising pH (alkalosis).
Three Major pH-Control Systems
- Chemical Buffer Systems (Immediate / Seconds):
- Bicarbonate-Carbonic Acid Buffer System (primary ECF buffer; operates at 20:1 ratio of HCO3− to H2CO3).
- Protein Buffers (hemoglobin, intracellular proteins; bind/release H+).
- Phosphate Buffer System (ICF and renal tubular fluid buffering).
- Respiratory System (Rapid / Minutes):
- Controls PaCO2 by altering minute ventilation.
- Hyperventilation blows off CO2→ reduces carbonic acid → raises pH.
- Hypoventilation retains CO2→ increases carbonic acid → lowers pH.
- Renal System (Slow / Hours to Days):
- Most powerful long-term regulator.
- Excretes excess H+ ions into urine, reabsorbs filtered HCO3−, and generates new HCO3− ions.
Four Primary Acid-Base Disorders
- Respiratory Acidosis:
- Primary Change: Elevated PaCO2>45mmHg; \text{pH} < 7.35$.\n - *Mechanism*: Alveolar hypoventilation leads to retention of \text{CO}_2.\n - *Causes*: COPD, severe asthma, acute pulmonary edema, airway obstruction, chest wall trauma, opioid overdose, CNS depression.\n - *Renal Compensation*: Kidneys retain \text{HCO}_3^-andexcrete\text{H}^+ into urine (slow process).\n- **Respiratory Alkalosis**:\n - *Primary Change*: Decreased \text{PaCO}_2 < 35\,\text{mmHg};\text{pH} > 7.45$.
- Mechanism: Alveolar hyperventilation leads to excessive washout of CO2.
- Causes: Acute anxiety, panic attacks, severe hypoxemia, high fever, early salicylate toxicity, mechanical ventilation overshoot.
- Renal Compensation: Kidneys excrete HCO3− into urine and retain H+.
- Metabolic Acidosis:
- Primary Change: Decreased HCO3−<22mEq/L; \text{pH} < 7.35$.\n - *Mechanism*: Excessive gain of metabolic acids or severe loss of base (\text{HCO}_3^-).\n - *Causes*: Diabetic Ketoacidosis (DKA), lactic acidosis (shock/tissue hypoxia), renal failure (uremia), severe diarrhea (loss of pancreatic/intestinal \text{HCO}_3^-).\n - *Respiratory Compensation*: Respiratory center stimulates deep, rapid respirations (**Kussmaul breathing**) to blow off \text{CO}_2.\n- **Metabolic Alkalosis**:\n - *Primary Change*: Elevated \text{HCO}_3^- > 26\,\text{mEq/L};\text{pH} > 7.45$.
- Mechanism: Loss of metabolic acid (H+) or gain of exogenous bicarbonate base.
- Causes: Severe vomiting, nasogastric suctioning, diuretic therapy, excess antacid administration, hypokalemia.
- Respiratory Compensation: Hypoventilation to retain CO2 (limited by arterial hypoxemia drive).
ABG Reasoning and Compensation
- Five-Step Systematic Interpretation:
- Analyze pH: Is it Acidic (<7.35), Alkaline (>7.45), or Normal (7.35–7.45)?
- Analyze PaCO2: Is it Acidic (>45) or Alkaline (<35)?
- Analyze HCO3−: Is it Acidic (<22) or Alkaline (>26)?
- Match pH with PaCO2 or HCO3− to establish the primary disorder.
- Determine status of compensation:
- Uncompensated: pH abnormal; opposing system remains within normal limits.
- Partially Compensated: pH remains abnormal; opposing system has shifted outside normal limits to compensate.
- Fully Compensated: pH has returned to normal range (7.35–7.45); both PaCO2 and HCO3− are abnormal. (Identify primary cause by determining which side of 7.40 the pH falls on).
Clinical Reasoning Chains & Rapid Review
- Heart failure →↑ Venous pressure →↑ Capillary hydrostatic pressure → Peripheral edema & pulmonary crackles.
- Liver cirrhosis → Hypoalbuminemia →↓ Plasma oncotic pressure → Generalized edema & ascites.
- Major burn →↑ Capillary permeability → Interstitial protein leakage → Severe edema + Hypovolemic shock.
- Hyponatremia → Hypotonic ECF → Water shifts into brain cells → Cerebral edema, headache, seizures.
- Hypernatremia → Hypertonic ECF → Water pulled out of brain cells → Neuronal dehydration, agitation, confusion.
- DKA treatment → Insulin drives K+ into cells → Precipitous drop in serum K+→ Ventricular dysrhythmias.
- Severe diarrhea → Direct gastrointestinal HCO3− loss → Metabolic acidosis → Kussmaul breathing.
- Opioid overdose → Severe CNS respiratory depression → Retains CO2→ Respiratory acidosis.
Chapter 5 - Inflammation, Healing, and Burns
Body Defenses: Timing, Specificity, and Memory
- First Line of Defense: Innate, physical, chemical, and anatomical barriers.
- Components: Intact skin, mucous membranes, respiratory cilia, gastric acid, lysozymes in tears/saliva, normal microbial flora.
- Timing: Immediate, continuous protection.
- Specificity: Non-specific.
- Memory: No immunological memory.
- Second Line of Defense: Innate, non-specific cellular and vascular responses.
- Components: Acute inflammatory response, phagocytosis (neutrophils, macrophages), fever, complement system, interferon.
- Timing: Rapid onset (minutes to hours post-injury).
- Specificity: Non-specific; responds identically regardless of injury cause.
- Memory: No immunological memory.
- Third Line of Defense: Adaptive, acquired specific immunity.
- Components: Humoral immunity (Blymphocytes / antibodies) and Cell-mediated immunity (Tlymphocytes).
- Timing: Slower primary response (days to weeks); rapid secondary response.
- Specificity: Highly specific for unique single antigens.
- Memory: Long-term immunological memory (B and T memory cells).
- Inflammation vs. Infection: Inflammation is a protective vascular and cellular tissue response to any injury (trauma, heat, ischemia, chemicals, infection). Infection is the invasion and colonization of tissue by pathogenic microorganisms. Infection triggers inflammation, but inflammation frequently occurs without infection.
Normal Capillary Exchange versus Inflammation
- Normal State: Arterial hydrostatic pressure pushes fluid, solutes, and nutrients out into interstitial space; venous plasma oncotic pressure pulls fluid and metabolic wastes back into the capillary. Lymphatics drain excess fluid.
- Inflammatory State: Chemical mediators induce local arteriole vasodilation (hyperemia) and endothelial contraction, creating enlarged inter-endothelial pores. Plasma proteins (albumin, fibrinogen) leak into the interstitial space. Interstitial oncotic pressure rises, pulling fluid into tissues → Protein-rich exudate and edema.
Causes and Sequence of Acute Inflammation
- Triggers: Mechanical trauma, thermal damage, ischemia/infarction, caustic chemicals, radiation, hypersensitivity reactions, microbial infection.
Vascular Phase
- Instantaneous, transient vasoconstriction of local arterioles.
- Rapid mediator release (histamine, bradykinin) causes profound arteriole vasodilation → Hyperemia (increased blood flow).
- Increased capillary permeability allows protein-rich fluid to leak into interstitial tissue.
- Fluid loss raises intravascular viscosity within local microcirculation, resulting in blood stasis.
Cellular Phase
- Margination: Leukocytes line up along the endothelial wall of slow-flowing blood vessels.
- Adhesion / Rolling: Leukocytes bind to cell adhesion molecules expressed on activated endothelium.
- Diapedesis / Emigration: Leukocytes squeeze through widened inter-endothelial gaps into tissue space.
- Chemotaxis: Leukocytes migrate down chemical concentration gradients toward the site of damage.
- Phagocytosis: Neutrophils (arriving first in 6-24 hours) and Macrophages (monocytes arriving in 24-48 hours) englobe, digest, and destroy pathogens and necrotic debris.
- Histamine:
- Source: Mast cell granules, basophils, platelets.
- Action: Immediate arteriole vasodilation and increased capillary permeability; causes pruritus and bronchial constriction.
- Bradykinin:
- Source: Plasma protein activation cascade (kininogen system).
- Action: Vasodilation, elevated permeability, and direct stimulation of pain receptors (nociceptors).
- Prostaglandins:
- Source: Arachidonic acid pathway synthesized via Cyclooxygenase (COX) enzymes in injured cells/mast cells.
- Action: Vasodilation, increased capillary permeability, sensitizes pain receptors, induces fever in hypothalamus.
- Leukotrienes:
- Source: Arachidonic acid pathway synthesized via Lipoxygenase in mast cells/leukocytes.
- Action: Prolonged capillary permeability, potent leukocyte chemotaxis, powerful bronchoconstriction.
- Cytokines (IL−1, TNF−α):
- Source: Activated macrophages, Tlymphocytes.
- Action: Induce systemic fever, leukocytosis, acute-phase liver protein production, promote fatigue/malaise.
- Complement Cascade:
- Source: Circulating plasma proteins (C1–C9).
- Action: Promotes opsonization (tags pathogens), leukocyte chemotaxis, histamine release, and membrane attack complex (MAC) cell lysis.
Five Cardinal Signs
- Redness (Rubor): Caused by local arteriole vasodilation and increased blood flow (hyperemia).
- Warmth (Calor): Caused by increased flow of warm blood to the peripheral injury site.
- Swelling (Tumor): Caused by fluid and protein accumulation in the interstitial space due to increased capillary permeability.
- Pain (Dolor): Caused by bradykinin and prostaglandins irritating nerve endings, exacerbated by pressure from edematous tissue.
- Loss of Function (Functio Laesa): Caused by tissue swelling, physical damage, and protective pain responses restricting movement.
Exudate Types
- Serous Exudate: Clear, watery fluid containing low protein concentrations and few white blood cells. (e.g., fluid inside burn blisters, allergic nasal secretions).
- Fibrinous Exudate: Thick, sticky exudate rich in fibrinogen and cellular debris. Indicates higher vascular permeability; carries high risk for fibrous scar adhesions.
- Purulent Exudate (Pus): Thick, yellow-green opaque fluid containing dead neutrophils, cellular debris, necrotic tissue, and bacteria. Indicates pyogenic bacterial infection.
- Abscess: Localized, walled-off collection of purulent exudate contained within a solid tissue.
- Hemorrhagic Exudate: Exudate filled with red blood cells; indicates severe capillary rupture and blood vessel trauma.
Local versus Systemic Effects
- Local Effects: Five cardinal signs, local exudate formation, tissue disruption, regional lymphadenopathy.
- Systemic Effects: High fever (pyrexia), malaise, fatigue, headache, loss of appetite (anorexia), leukocytosis, elevated liver acute-phase proteins.
Fever Mechanism
- Pyrogens (IL−1, TNF−α, bacterial endotoxins) released → Stimulates hypothalamic synthesis of Prostaglandin E2 (PGE2) → Hypothalamic thermostat set-point elevated → Body perceives current temperature as cold → Triggers shivering, peripheral vasoconstriction (chills, pale cool skin) → Core temperature reaches new higher set-point → Pyrogens decline → Set-point resets to normal → Sweating and vasodilation occur ("fever breaks").
Laboratory Markers of Inflammation
- Leukocytosis: Elevated total WBC count (>11,000/μL), often with a "shift to the left" (increased immature band neutrophils indicating acute infection).
- C-Reactive Protein (CRP): Acute-phase protein synthesized by liver during inflammation. Non-specific marker of active inflammation.
- Erythrocyte Sedimentation Rate (ESR): Elevated fibrinogen causes red blood cells to clump and settle rapidly in a tube; non-specific marker of systemic inflammation.
Acute versus Chronic Inflammation
- Acute Inflammation: Sudden onset, short duration (days to weeks). Predominant cells: Neutrophils. Prominent vascular permeability, exudate, and cardinal signs. Resolves or progresses to scar/chronic state.
- Chronic Inflammation: Insidious onset, long duration (months to years). Predominant cells: Macrophages, Lymphocytes, Plasma cells, Fibroblasts. Less exudate/edema, but continuous simultaneous tissue destruction, repair attempts, and extensive fibrosis (scarring).
- Granuloma: Specialized nodular focus of chronic inflammation composed of aggregated epithelioid macrophages surrounded by lymphocytes, created to wall off persistent indigestible substances (e.g., Mycobacterium tuberculosis, foreign bodies).
Treatment of Inflammation
- Aspirin (Acetylsalicylic Acid - ASA): Irreversibly inhibits COX−1 and COX−2 enzymes → suppresses prostaglandin synthesis. Provides anti-inflammatory, analgesic, antipyretic, and anti-platelet aggregation effects. Adverse Effects: GI ulceration, bleeding, tinnitus.
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Reversibly inhibit COX−1 and COX−2 (e.g., ibuprofen, naproxen). Anti-inflammatory, analgesic, antipyretic. Adverse Effects: Gastric distress, fluid retention, renal impairment.
- Acetaminophen (Paracetamol): Central nervous system analgesic and antipyretic. Lacks peripheral anti-inflammatory or anti-platelet properties. High doses cause hepatotoxicity.
- Glucocorticoids (Corticosteroids): Potent synthetic anti-inflammatory drugs (e.g., prednisone, dexamethasone).
- Mechanisms: Blocks Phospholipase A2 (stopping arachidonic acid cascade), inhibits cytokine synthesis, reduces capillary permeability, impairs leukocyte chemotaxis/phagocytosis, suppresses immune response.
- Adverse Effects: High risk of infection, delayed wound healing, hyperglycemia, osteoporosis, muscle catabolism, sodium/water retention, hypertension, adrenal gland suppression.
- Nonpharmacologic (RICE): Rest, Ice (causes local vasoconstriction to minimize swelling early), Compression, Elevation (promotes venous/lymphatic drainage).
Healing
- Resolution: Minimal tissue damage; damaged cells recover and tissue returns to normal (e.g., mild sunburn).
- Regeneration: Damaged tissue cells are replaced by identical functional cells via mitotic division of neighboring parenchymal cells. (Occurs in epithelial tissue, liver, bone marrow).
- Replacement / Repair: Severe tissue damage or destruction of non-dividing permanent cells (cardiac myocytes, neurons) results in replacement of functional tissue with collagenous fibrous scar tissue.
Primary vs. Secondary Intention Healing
- First / Primary Intention: Clean wound edges closely approximated (e.g., surgical incision with sutures), minimal tissue loss, minimal granulation tissue, rapid healing, small thin scar.
- Second / Secondary Intention: Large open tissue deficit or infected wound (e.g., pressure ulcer, major burn), wound edges widely separated, requires extensive formation of granulation tissue and wound contraction, slow healing, large prominent scar.
- Promoting Factors: Adequate blood flow/oxygenation, high-protein diet, Vitamin C and Zinc supplementation, clean wound environment, youthful age.
- Delaying Factors: Ischemia, hypoxia, infection, foreign material, malnutrition, corticosteroid therapy, uncontrolled diabetes mellitus, advanced age.
Scar Complications
- Loss of Function: Scar tissue lacks specialized functional structures (glands, hair follicles, sensory nerves, contractile muscle fibers).
- Contractures: Non-elastic fibrous scar tissue shortens over time, causing severe joint fixation and restricted range of motion.
- Obstruction: Scar formation in tubular organs (esophagus, intestines, ureters) narrows the lumen, causing strictures.
- Adhesions: Fibrous bands of scar tissue that abnormally connect adjacent serous surfaces (e.g., loop of intestine to peritoneal wall), risking bowel obstruction.
- Hypertrophic Scar / Keloid: Excessive, overabundant collagen deposition during repair. Keloids represent raised, firm scar growth that extends beyond original wound boundaries.
- Ulceration: Poor vascularity of scar tissue leads to tissue breakdown and recurring ulcer formation.
Burns: Cause and Depth
- Etiologies: Thermal (flame, hot liquid, steam), Chemical (acids, alkalis), Electrical, Radiation, Friction.
Depth Classification
- Superficial (First-Degree): Involves epidermis only. Red, dry, painful, blanches with pressure. No blistering. Heals rapidly by regeneration without scarring (e.g., mild sunburn).
- Superficial Partial-Thickness (Second-Degree): Involves epidermis and upper dermis. Red, moist, extremely painful, fluid-filled blisters present. Heals with minimal scarring.
- Deep Partial-Thickness (Second-Degree): Involves epidermis and deeper dermis. Mottled red/white, waxy, less blanching, blisters present. Sensation reduced due to partial nerve damage. Slow healing; high scar/contracture risk.
- Full-Thickness (Third-Degree): Complete destruction of epidermis, dermis, and epidermal appendages; may extend into subcutaneous fat. Hard, leathery, charred or dark brown/white eschar. Center is painless because sensory nerve endings are completely destroyed (surrounding partial-thickness areas remain painful). Cannot regenerate; requires skin grafting.
- Fourth-Degree: Extends beyond skin into underlying muscle, fascia, tendons, and bone. Charred appearance. Requires major surgical reconstruction or amputation.
Burn Size: Adult Rule of Nines
- Adult Body Surface Area Allocations:
- Head and Neck: 9%
- Anterior Trunk: 18%
- Posterior Trunk: 18%
- Entire Right Arm: 9%
- Entire Left Arm: 9%
- Entire Right Leg: 18%
- Entire Left Leg: 18%
- Perineum / Genitalia: 1%
- Scattered Burns: Patient's palm (including fingers) equals approximately 1% total body surface area (TBSA).
Emergency Priorities for Burns
- Stop the burning process, remove smoldering clothing, flush chemical burns with water.
- Airway, Breathing, Circulation (ABCs): Assess for inhalation injury (soot around mouth/nares, singed nasal hairs, hoarseness, stridor, carbonaceous sputum). Inhalation injury causes severe, rapid airway edema → prepare for immediate endotracheal intubation.
- Administer 100% high-flow oxygen for suspected inhalation or carbon monoxide poisoning.
- Cool thermal burns briefly with cool water (do not apply ice or submerge large areas to avoid hypothermia).
- Establish peripheral IV access and initiate massive isotonic fluid resuscitation (Lactated Ringer's) to counteract burn shock.
Systemic Pathophysiology of Major Burns
- Burn Shock (Hypovolemic / Distributive): Massive release of inflammatory mediators causes widespread capillary permeability. Plasma proteins leak into tissue spaces → Massive fluid shift out of vascular space into interstitial compartment (third spacing). Blood volume plummets → Drop in cardiac output → Severe hypotension, hemoconcentration, hypovolemic shock, and acute renal failure.
- Respiratory Failure: Inhalation of toxic chemical smoke or superheated steam causes acute laryngeal edema, bronchospasm, interstitial pulmonary edema, alveolar damage, and acute respiratory distress syndrome (ARDS).
- Infection and Sepsis: Loss of the primary skin barrier, presence of necrotic devitalized eschar, impaired blood flow, and systemic immunosuppression create extreme vulnerability to bacterial superinfections (Pseudomonas aeruginosa, Staphylococcus aureus), leading to sepsis and septic shock.
- Hypermetabolic State: Catecholamine, cortisol, and glucagon surge dramatically increases metabolic rate, caloric expenditure, body temperature, and catabolism. Severe muscle wasting occurs without aggressive nutritional support.
Burn Healing & Pediatric Concerns
- Healing Difficulties: Devitalized eschar fosters bacteria, ischemia delays tissue repair, hypermetabolism drains protein stores, and eschar formation creates constricting circumferential bands requiring emergency surgical escharotomy to restore circulation or chest wall expansion.
- Pediatric Considerations: Children have a proportionally larger head surface area, thinner skin (deeper burns from same exposure), smaller fluid reserves, higher surface-area-to-mass ratio (rapid heat loss/hypothermia), and higher vulnerability to shock. Scars do not grow with the child, requiring repeated contracture release surgeries.
Chapter 6 - Infection
Infection vs. Colonization and Inflammation
- Infection: Entry, establishment, replication, and tissue injury caused by pathogenic microorganisms within a host.
- Colonization: Microorganisms reside and multiply on host body surfaces (skin, gut) without causing tissue invasion, damage, or clinical response.
- Contamination: Accidental presence of microbes on environmental surfaces or laboratory specimens.
- Inflammation: Host vascular and cellular tissue response to injury; occurs with or without infectious organisms.
- Normal Flora: Commensal microorganisms permanently residing on non-sterile skin and mucous membranes. Benefit host by competing for nutrients and producing antimicrobial substances.
- Opportunistic Infection: Caused by normal flora or benign organisms when host immune defenses are suppressed or when flora translocates to a sterile body site.
Bacteria
- Definition: Unicellular prokaryotic organisms lacking a membrane-bound nucleus; contain double-stranded DNA, replicate independently via binary fission, and possess a rigid peptidoglycan cell wall.
- Shapes & Arrangements:
- Bacilli: Rod-shaped.
- Cocci: Spherical. (Diplococci = pairs; Streptococci = chains; Staphylococci = clusters).
- Spirochetes / Spirilla: Spiral or curved shapes.
- Key Bacterial Structures:
- Peptidoglycan Cell Wall: Maintains shape, protects against osmotic lysis. Gram-positive has a thick peptidoglycan layer; Gram-negative has a thin peptidoglycan layer plus an outer lipopolysaccharide (LPS) membrane.
- Capsule / Slime Layer: Mucopolysaccharide coat that inhibits host phagocytosis and facilitates tissue adherence.
- Pili / Fimbriae: Hair-like projections aiding tissue attachment and genetic transfer via conjugation.
- Plasmids: Extrachromosomal DNA rings carrying antibiotic resistance genes (R-factors).
- Endospores: Highly resistant dormant structures formed by certain Gram-positive bacilli (Clostridium, Bacillus) to survive extreme heat, drying, and disinfectants. Spores do not serve reproductive functions; they serve survival functions.
Exotoxins vs. Endotoxins
- Exotoxins: Soluble proteins secreted continuously by living bacteria (predominantly Gram-positive). Highly toxic, target specific tissues (e.g., neurotoxins like tetanus toxin, enterotoxins). Stimulate antibody production (antitoxins).
- Endotoxins: Lipopolysaccharide (LPS) components contained within the outer cell wall of Gram-negative bacteria. Released upon bacterial cell death/lysis.
- Pathophysiology: Endotoxin release → Activates macrophages, complement, and coagulation cascades → Massive cytokine release (IL−1, TNF−α) → Severe systemic vasodilation, capillary leak, fever, disseminated intravascular coagulation (DIC), and septic shock.
Viruses
- Definition: Small obligate intracellular parasites consisting of a nucleic acid core (either DNA or RNA, never both) enclosed in a protein coat (capsid), sometimes surrounded by a lipid envelope.
- Active Replication Steps:
- Absorption / Attachment: Virus binds to specific host cell surface receptors.
- Penetration and Uncoating: Viral nucleic acid enters host cell cytoplasm.
- Synthesis: Viral genome takes control of host cell metabolic machinery, synthesizing viral proteins and replicating viral nucleic acids.
- Assembly: New viral capsids and genomes assemble into complete virions.
- Release: Virions exit host cell via cell lysis (killing host cell) or budding.
- Antibiotic Ineffectiveness: Antibiotics target bacterial walls, ribosomes, and metabolic pathways; viruses lack these structures, rendering antibiotics useless.
- Latent Infection: Viral genome integrates into host DNA, remaining silent without active viral replication or cell lysis. Reactivates later during stress or immunosuppression (e.g., Herpes simplex, Varicella-zoster).
Other Infectious Agents
- Chlamydiae: Obligate intracellular bacteria lacking full metabolic mechanisms. Cause sexually transmitted infections (pelvic inflammatory disease, ectopic pregnancy, infertility).
- Rickettsiae: Gram-negative obligate intracellular bacteria transmitted by insect vectors (ticks, lice, fleas). Cause Rocky Mountain spotted fever and typhus; target endothelial lining of blood vessels.
- Mycoplasmas: Smallest free-living bacteria that completely lack a cell wall. Cause atypical ("walking") pneumonia. Intrinsic resistance to cell-wall-inhibiting antibiotics (penicillins).
- Fungi: Eukaryotic organisms possessing rigid cell walls containing chitin. Include unicellular yeasts and multicellular molds.
- Candida albicans: Opportunistic yeast causing oral thrush, vaginitis, and invasive candidiasis in immunocompromised hosts.
- Pneumocystis jirovecii: Opportunistic fungus causing severe pneumonia in advanced HIV/AIDS.
- Protozoa: Eukaryotic, unicellular organisms lacking cell walls. Frequently parasitic (Plasmodium causing malaria, Trichomonas vaginalis, Entamoeba histolytica).
- Helminths: Multicellular parasitic worms (flatworms, roundworms, tapeworms). Life cycles involve ova, larvae, and adult worms.
- Prions: Misfolded infectious protein particles containing no nucleic acid. Induce abnormal misfolding of brain host proteins → Progressive, non-inflammatory, fatal neurodegenerative diseases (e.g., Creutzfeldt-Jakob disease). Highly resistant to standard sterilization techniques.
Chain of Infection & Modes of Transmission
- Six Essential Links:
- Infectious Agent: Pathogenic organism.
- Reservoir: Environment/host where pathogen lives and multiplies (human, animal, soil, water).
- Portal of Exit: Route pathogen leaves reservoir (respiratory tract, stool, blood, exudate).
- Mode of Transmission: Mechanism of movement from reservoir to new host.
- Portal of Entry: Route pathogen enters susceptible host (mucous membrane, broken skin, invasive line).
- Susceptible Host: Person with reduced defense mechanisms.
- Modes of Transmission:
- Direct Contact: Immediate physical contact between infected source and host (touching lesion, intercourse).
- Indirect Contact: Involves an intermediate inanimate object (fomite) such as contaminated medical equipment or door handles.
- Droplet: Large respiratory particles thrown short distances (<6feet) via coughing or sneezing onto host mucous membranes.
- Aerosol / Airborne: Tiny droplet nuclei suspended in air currents for long periods and traveled over long distances.
- Vector-Borne: Insect or animal acts as intermediate host or transmitter (mosquitoes, ticks).
Host Resistance, Pathogenicity, and Virulence
- Decreased Host Resistance Factors: Extreme age, malnutrition, chronic illness, immunosuppressive therapy, severe stress, physical trauma, impaired anatomical barriers, indwelling invasive catheters.
- Pathogenicity: The innate ability of a microorganism to cause disease.
- Virulence: The degree or intensity of pathogenicity of an organism.
- Virulence Factors: Bacterial capsules, pili, destructive enzymes (hyaluronidase, hemolysins), exotoxins/endotoxins, antigenic mutation capabilities, biofilm production.
Health-Care-Associated Infection & Precautions
- Health-Care-Associated Infections (HAIs / Nosocomial): Infections acquired during hospitalization or healthcare delivery that were not present or incubating upon admission.
- Standard Precautions: Basic infection prevention practices applied to all patients regardless of suspected infection status whenever exposure to blood, body fluids, non-intact skin, or mucous membranes is possible. Includes hand hygiene, PPE, safe injection practices.
- Transmission-Based Precautions:
- Contact Precautions: Gown and gloves for direct/indirect contact with organisms like MRSA, C. difficile.
- Droplet Precautions: Surgical mask within 3-6 feet for pathogens like influenza, pertussis, meningococcus.
- Airborne Precautions: N95 respirator, negative-pressure isolation room for airborne pathogens like Tuberculosis, Measles, Varicella.
Cleaning, Disinfection, Antisepsis, Sterilization
- Cleaning: Physical removal of organic material and soil. Must precede disinfection or sterilization because organic debris shields microbes.
- Antisepsis: Application of chemical agents to living tissue / skin to inhibit or destroy pathogens.
- Disinfection: Chemical or physical destruction of most pathogenic microbes on inanimate objects; does not reliably kill bacterial spores.
- Sterilization: Complete destruction or removal of all viable microorganisms, including bacterial spores. Accomplished via autoclaving (moist heat under pressure), chemical sterilants, or ethylene oxide gas.
Physiology and Time Course of Infection
- Incubation Period: Time between exposure and onset of clinical symptoms; pathogen actively multiplying.
- Prodromal Period: Vague, non-specific symptoms present (fatigue, mild fever, headache). Highly infectious.
- Acute / Illness Period: Pathogen reaches peak multiplication; full, characteristic local and systemic signs present.
- Convalescent / Decline Period: Infection cleared by host defenses/treatment; symptoms subside, tissue repair begins.
Manifestations, Diagnosis, and Antimicrobial Stewardship
- Diagnostic Identification: Culture and Sensitivity (C&S) testing isolates specific pathogens and determines antimicrobial susceptibility. Always obtain culture specimens prior to initiating antibiotic therapy whenever possible.
- Bactericidal vs. Bacteriostatic: Bactericidal drugs directly kill bacteria; bacteriostatic drugs inhibit bacterial growth/replication, relying on host immune defenses to clear the infection.
- Broad vs. Narrow Spectrum: Broad-spectrum acts against Gram-positive and Gram-negative bacteria (higher risk for superinfections like C. difficile); narrow-spectrum targets specific organisms.
- Five Major Antibacterial Mechanisms:
- Inhibition of Cell Wall Synthesis: Penicillins, Cephalosporins (selective toxicity because human cells lack peptidoglycan cell walls).
- Disruption of Cell Membrane: Polymyxins.
- Inhibition of Protein Synthesis: Tetracyclines, Aminoglycosides, Macrolides (targets bacterial 30S/50S ribosomes).
- Inhibition of Nucleic Acid Synthesis: Fluoroquinolones (inhibits DNA gyrase/topoisomerase).
- Inhibition of Essential Metabolite Synthesis: Sulfonamides (blocks folic acid synthesis pathway).
- Antimicrobial Stewardship: Use narrow-spectrum agents when culture results are known, ensure complete course completion, avoid prescribing antibacterials for viral infections, and enforce hand hygiene to prevent resistance development.
Chapter 7 - Immunity and Abnormal Immune Responses
Innate versus Adaptive Defenses
- Innate Defense: Non-specific protection present at birth. Responds immediately to pathogens without requiring prior exposure or specific antigen recognition. Includes physical barriers, phagocytes, natural killer cells, complement, and acute inflammation.
- Adaptive Defense: Specific immune response triggered by specific foreign antigens. Involves antigen processing, clonal expansion, antibody production, and cell-mediated toxicity. Features specificity and immunological memory.
Immune Structures and Cells
- Bone Marrow: Primary lymphoid organ; site of hematopoiesis (origin of all blood cells). Site of Bcell maturation.
- Thymus: Primary lymphoid organ; site of Tcell maturation and self-tolerance processing.
- Secondary Lymphoid Structures: Lymph nodes, Spleen, Tonsils, Mucosa-Associated Lymphoid Tissue (MALT). Filter body fluids, trap antigens, facilitate antigen presentation, and serve as sites for B and T cell activation.
- Major Immune Cell Roles:
- Neutrophils: Primary phagocytes in early acute bacterial inflammation.
- Monocytes / Macrophages: Engulf pathogens, process antigens, act as key Antigen-Presenting Cells (APCs), secrete cytokines.
- BLymphocytes: Primary effectors of Humoral Immunity. Differentiate into Plasma Cells (which secrete specific antibodies) and Memory B Cells.
- Helper T Cells (CD4+): Master coordinators of adaptive immunity. Secrete cytokines that activate B cells, Cytotoxic T cells, and macrophages. Targeted and destroyed by HIV.
- Cytotoxic T Cells (CD8+): Direct cellular killing of virus-infected cells, intracellular pathogens, and tumor cells via perforins and granzymes.
- Natural Killer (NK) Cells: Innate lymphocytes that lyse virus-infected and tumor cells without prior antigen sensitization.
- Humoral Immunity: Mediated by Blymphocytes and circulating antibodies. Specifically targets extracellular pathogens, toxins, and bacteria circulating in blood and tissue fluids.
- Cell-Mediated Immunity: Mediated by sensitized Tlymphocytes (CD4+ and CD8+). Specifically targets intracellular pathogens (viruses inside host cells, intracellular bacteria), malignant cells, and foreign tissue transplants.
Antibodies / Immunoglobulins
- IgG: Most abundant circulating antibody (80% of serum Igs). Dominates secondary immune responses. Crosses the placenta to provide passive immunity to newborn. Activates complement and opsonizes bacteria.
- IgM: First antibody synthesized during a primary immune response. Pentamer structure; potent activator of complement and agglutination.
- IgA: Primary secretory antibody found in mucous membrane secretions (tears, saliva, colostrum, respiratory/GI tracts). Protects epithelial surfaces.
- IgE: Binds to receptors on mast cells and basophils. Cross-linking by allergens triggers mast cell degranulation and histamine release. Mediates Type I hypersensitivity (allergic) reactions and defends against parasitic worms.
- IgD: Present on naive Bcell surface membranes; functions as an antigen receptor initiating Bcell differentiation.
Methods of Acquiring Immunity
- Natural Active: Antigen entered naturally through clinical or subclinical infection → Host immune system produces antibodies and long-term memory cells (e.g., recovery from chickenpox).
- Artificial Active: Specific antigen introduced artificially via vaccine or toxoid → Host immune system actively synthesizes antibodies and memory cells without causing full disease (e.g., MMR vaccination).
- Natural Passive: Preformed antibodies transferred naturally from mother to fetus across placenta (IgG) or to infant via breast milk/colostrum (IgA). Provides immediate, temporary protection; forms no memory.
- Artificial Passive: Preformed antibodies or hyperimmune globulin injected directly into individual (e.g., rabies immune globulin, antivenom). Provides immediate, short-term protection; forms no memory.
Hypersensitivity Overview
- Type I (Immediate / Anaphylactic / IgE-Mediated):
- Mechanism: Allergen binds to specific IgE antibodies pre-attached to mast cells → Triggers rapid mast cell degranulation and release of histamine, leukotrienes, and prostaglandins.
- Examples: Allergic rhinitis, asthma, hives, food allergies, acute systemic anaphylaxis.
- Type II (Cytotoxic / Antibody-Mediated):
- Mechanism: IgG or IgM antibodies bind directly to fixed antigens on target cell surface → Triggers complement-mediated lysis or phagocytosis.
- Examples: Incompatible ABO blood transfusion reactions, Hemolytic Disease of the Newborn (Rh incompatibility), Myasthenia gravis.
- Type III (Immune Complex-Mediated):
- Mechanism: Soluble antigen-antibody (IgG/IgM) complexes form in circulation and deposit into vascular walls or tissue membranes (joints, kidneys) → Activates complement and recruits neutrophils → Tissue destruction.
- Examples: Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, Post-streptococcal glomerulonephritis, Serum sickness.
- Type IV (Delayed / Cell-Mediated):
- Mechanism: Sensitized Tlymphocytes encounter antigen and release cytokines 24-72 hours later, recruiting macrophages that cause tissue injury.
- Examples: Tuberculin (PPD) skin test reaction, Contact dermatitis (poison ivy, nickel allergy), Transplant rejection.
Allergy versus Anaphylaxis
- Localized Allergy: Confined to local site of exposure (itching, sneezing, localized hives). Stable vital signs.
- Anaphylaxis: Life-threatening, severe systemic Type I hypersensitivity reaction.
- Pathophysiology: Widespread mast cell degranulation releases systemic histamine and mediators → Severe systemic vasodilation + profound capillary leak → Distributive shock (hypotension) → Concurrent bronchial smooth muscle constriction + laryngeal mucosal edema → Airway collapse and asphyxiation.
- Manifestations: Pruritus, hives, angioedema (swollen lips/tongue), hoarseness, stridor, dyspnea, wheezing, severe hypotension, tachycardia, dizziness, collapse.
- First-Line Emergency Priority: Immediate Intramuscular (IM) Epinephrine (causes bronchodilation and vasoconstriction). Antihistamines and corticosteroids are secondary adjuncts.
Autoimmunity and Systemic Lupus Erythematosus (SLE)
- Autoimmunity: Failure of self-tolerance; host immune system develops autoantibodies or autoreactive T cells that attack self-antigens.
- SLE Pathophysiology: Chronic multi-system autoimmune disease. Characterized by production of Antinuclear Antibodies (ANA) against self-nuclear components (DNA, histones). Autoantibodies bind nuclear antigens forming circulating immune complexes that deposit in microvasculature, renal glomeruli, joints, skin, and serosa → Complement activation → Chronic vasculitis, inflammation, ischemia, and tissue necrosis.
- Clinical Manifestations: Malaise, fever, non-erosive joint polyarthralgias, classic malar "butterfly" rash across cheeks and nasal bridge, photosensitivity, oral ulcers, pleuritis, pericarditis, and lupus nephritis.
- Lupus Nephritis Marker: Immune complex deposition damages glomerular basement membrane → Protein leaks into urine (Proteinuria) along with hematuria. Proteinuria indicates active renal involvement.
- Diagnostic Findings: Positive ANA, high anti-double-stranded DNA (anti-dsDNA) titers, positive anti-Smith (anti-Sm) antibodies, low serum complement levels (C3, C4 consumed during active flare).
Immunodeficiency and HIV/AIDS
- Immunodeficiency: Partial or total loss of function of one or more components of the immune system. Leads to recurrent, severe, persistent infections and increased risk of malignancy.
- Primary: Congenital genetic defects (e.g., Severe Combined Immunodeficiency - SCID).
- Secondary / Acquired: Caused by viral infection (HIV), immunosuppressive drugs, radiation, malnutrition, splenectomy, advanced aging.
Human Immunodeficiency Virus (HIV) and AIDS
- Etiology: Enveloped retrovirus possessing single-stranded RNA and key enzymes: Reverse Transcriptase, Integrase, and Protease.
- Target Cells: Specifically targets cells expressing the CD4 surface receptor, primarily CD4+ Helper T Lymphocytes.
- Pathophysiological Replication Sequence:
- Viral glycoprotein (gp120) attaches to CD4 receptor and chemokine co-receptor (CCR5 or CXCR4).
- Viral envelope fuses with host cell membrane, releasing viral RNA and enzymes into cytoplasm.
- Reverse Transcriptase copies viral RNA into single and then double-stranded viral DNA.
- Integrase inserts viral DNA into the host cell's nuclear genome (forming a latent provirus).
- Host machinery transcribes viral RNA and synthesizes viral polyproteins.
- Protease cleaves long viral polyproteins into functional structural proteins as new virions assemble and bud off.
- Pathophysiological Consequence: Progressive destruction and loss of CD4+ Helper T cells → Complete breakdown of both humoral and cell-mediated adaptive immunity.
- Transmission: Contact with blood, semen, vaginal secretions, breast milk. (Not spread by casual contact, saliva, sweat, or vectors). Undetectable viral load = Untransmittable (U=U).
- Diagnostic Criteria for AIDS: HIV-positive status plus either a CD4+ T cell count <200/μL OR the presence of an AIDS-defining opportunistic infection / malignancy (e.g., Pneumocystis jirovecii pneumonia, Kaposi sarcoma, Cytomegalovirus retinitis, Esophageal candidiasis, Wasting syndrome).
- Antiretroviral Therapy (ART): Combination therapy using multiple drug classes (NRTIs, NNRTIs, INSTIs, Protease Inhibitors) to suppress viral replication, lower viral load to undetectable levels, preserve CD4 counts, and prevent resistance.
Cross-Chapter Master Concept Maps
- Injury-to-Shock Pathway: Tissue Injury / Infection / Allergen → Mediator Release (Histamine, Cytokines) → Arteriole Vasodilation + Increased Capillary Permeability → Plasma Protein and Fluid Shift into Interstitial Space → Severe Edema / Third Spacing → Drop in Intravascular Volume → Decreased Venous Return and Cardiac Output → Arterial Hypotension and Poor Tissue Perfusion → Cellular Hypoxia & Anaerobic Metabolism → Lactic Acidosis and Multi-Organ Dysfunction.
- Potassium-Acid-Base Relationship: Tissue Hypoxia / Shock → Lactic Acid Accumulation (Metabolic Acidosis) → Extracellular H+ increases $\rightarrow \text{H}^+shiftsintocellsinexchangefor\text{K}^+ \rightarrow∗∗AcuteHyperkalemia∗∗\rightarrowRiskforfatalcardiacdysrhythmias.Upontreatmentwithinsulinandacidosiscorrection,\text{K}^+shiftsbackintocells\rightarrow Risk for **Acute Hypokalemia**.\n\n# Final Exam Checklist\n\n- Explain differences between cellular adaptations (atrophy, hypertrophy, hyperplasia, metaplasia, dysplasia, anaplasia).\n- Distinguish apoptosis from necrosis and state the 4 structural necrosis patterns.\n- Describe the 4 primary mechanisms producing edema.\n- Explain Starling forces (capillary hydrostatic push vs. plasma oncotic pull).\n- State normal ABG ranges (\text{pH}, \text{PaCO}_2, \text{HCO}_3^-) and identify acid-base disorders and compensation.\n- Explain local vs. systemic inflammation and the 5 cardinal signs.\n- Differentiate primary vs. secondary intention wound healing.\n- Calculate adult burn surface areas using the Rule of Nines.\n- State emergency priorities for major burns and explain burn shock pathophysiology.\n- Explain Gram-negative endotoxin release and the septic shock pathway.\n- List the 6 links in the chain of infection and methods to break each link.\n- Differentiate Humoral (B\,\text{cell})vs.Cell−Mediated(T\,\text{cell}) immunity.\n- State functions of IgG, IgM, IgA, IgE, IgD.\n- Explain the 4 types of hypersensitivity reactions.\n- Identify the first-line medication for anaphylaxis and its rationale.\n- Explain SLE pathophysiology, diagnostic antibodies, and lupus nephritis markers.\n- Describe HIV replication steps, target CD4$$ cells, and AIDS diagnostic criteria.
Source Basis and Course Alignment
- Course Alignment: Prepared directly from JBU NUR3114 course learning objectives and Gould's Pathophysiology lecture materials (Chapters 1, 2, 5, 6, and 7).
- Primary Textbook Basis: VanMeter, K. C., & Hubert, R. J. (2023). Gould's Pathophysiology for the Health Professions (7th ed.). Elsevier.
- Clinical Application Note: Focused explicitly on underlying pathophysiological cause-to-effect mechanisms, clinical manifestations, emergency priorities, and NCLEX reasoning standards.